20 (AIDX) Net Income towards Common Stockholders (2025 - 2026)
20's (AIDX) quarterly Net Income towards Common Stockholders came in at -$2.1 million in Q1 2026, down 177.36% YoY from $2.7 million in Q1 2025, and down 177.36% on a QoQ basis from -$764577.0 in Q1 2025.
20 (AIDX) Net Income towards Common Stockholders (2025 - 2026) Analysis & Trends
20 (AIDX) has 2 years of Net Income towards Common Stockholders data on file, last reported at -$2.1 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 177.36% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.9 million (changed N/A YoY) and the FY2025 annual result came in at -$3.8 million, up 30.86% from the prior year.
- Net Income towards Common Stockholders fell to -$2.1 million in Q1 2026, from -$764577.0 in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$764577.0 in Q1 2025 to a low of -$2.1 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 201.00 Mn |
| 10 | 20 | 5.56 Mn | 1.01 Mn | 304,727.00 | -2.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.12 Mn |
| Mar 31, 2025 | -764,577.00 |